Ubs Group Ag Assertio Holdings, Inc. Call Options Transaction History

Ubs Group Ag

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	BUY	$2.52 - $5.69 $48,132 - $108,679	19,100 Added 2.28%	857,000 $2.19 Million
Q2 2023 Aug 11, 2023	BUY	$5.0 - $7.66 $2.15 Million - $3.3 Million	430,500 Added 105.67%	837,900 $4.54 Million
Q1 2023 May 12, 2023	BUY	$3.54 - $6.66 $1.44 Million - $2.71 Million	407,400 New	407,400 $2.6 Million

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $44.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.